Suvenpharma
Suven Pharma Breaks Out Like a Fever Dream"Suven Pharma Breaks Out Like a Fever Dream! 💊📈 #PharmaStocksGoBoom"
I. Current Price Action:
Price: ₹787.35
Change: +58.10 (+7.97%)
Volume: 3.673M (Higher than the number of pills in your grandma's medicine cabinet!)
II. Key Observations:
Breakout Bonanza: SUVENPHAR has busted through its long-term resistance faster than a hypochondriac racing to WebMD.
Side Channel Escape: The stock just broke out of its side channel, showing more excitement than a kid in a candy store (or should we say, pharmacy?).
Volume Surge: Trading volume is higher than the line at the doctor's office during flu season. This suggests strong conviction in the move.
Support Levels: The previous resistance around ₹760 could now act as support. If it holds, it'll be stronger than the taste of cough syrup.
III. Trading Idea:
For the brave pill-poppers (I mean, traders), riding this breakout could be more thrilling than reading the side effects on a medication leaflet. But remember, chasing stocks can be as dangerous as self-diagnosing on the internet!
Potential Targets:
🎯 Short-term: ₹820 (As ambitious as promising to exercise more)
🎯 Mid-term: ₹850 (Reaching for the stars, or at least the top shelf of the medicine cabinet)
IV. Risks:
If this breakout fails, the stock could drop faster than your New Year's resolution to eat healthier. Keep an eye on overall market health and be ready to take your profits before they expire like old medication.
V. Final Thoughts:
Suven Pharmaceuticals has finally broken out of its consolidation, potentially setting the stage for a rally that could cure your portfolio's ailments. Will it continue to climb, or suffer from nasty side effects? Only time will tell, but one thing's for sure – this stock is more exciting than reading the fine print on a prescription label!
Disclaimer: This analysis is about as reliable as WebMD's symptom checker. Always do your own research and consult a financial advisor before making investment decisions. Happy trading, and may your profits be as plentiful as the pills in a pharmacy! 💊🚀
SUVEN PHARMACEUTICALS for 25% (approx..) GainSUVEN PHARMACEUTICALS is showing breakout on weekly chart. Volume is also support on this breakout. But I am interested in its Shareholding Pattern . you can check it on screener.in
( www.screener.in )
CMP : 550
TG : 650
SL : Below 21 daily EMA
Stock's selection based on 5 Point Analysis:
1: Idea : Breakout.
2: Support : Volume , Delivery & VWAP.
3: Technical : 9/21/55/200-EMA, RS>0, MACD, RSI & Super trend up.
4: Fundamental : PE, PAT, Industry & peer PE and sector performance.
5: Timing : Entry Timing on daily chart.
Disclaimer : It is my personal view as a trader and for educational purpose only. Equity market involves risk .
Please consult your financial adviser before taking any decision.
SUVENPHAR - WEEKLY CHART ANALYSISThe stock on a monthly timeframe have retraced to 23.6% and is now showing strength in the recent past.
On a weekly timeframe it was consolidating in a very narrow range in the last 6 months and finally breaking out few weeks back with good volume support.
541-559 is the supply zone and it had close this week inside this zone. It should either consolidate a week or two in this zone and there after continue its upward journey.
500-520 levels shall now act as a support and stock should not close below it on a weekly timeframe.
590-618-630 these levels are small resistances. where the stock might face some selling but that shall be absorbed soon and those are the all time high levels.
As per the trend based fib 934 is an ideal level that shall be tested in the long term.
My view stands invalid if the stock closes below 461-479 support zone on weekly basis.
Disclaimer: This is just an analysis and not a buy/sell recommendation. If you intend to trade this counter then do your own due diligence and trade at your own risk.
SUVENPHAR - Investment IdeaSUVEN PHARMACEUTICALS LTD
Market Cap: 111 BN
PE: 25
SECTOR PE: 30
Debt to Equity: .06
Quarterly results
June 22 = 1.08 BN
June 21 = 1.05 BN
Net Sales
June 22 = 3.39 BN
June 21 = 2.64 BN
EBITDA
June 22 = 1.61 BN
June 21 = 1.20 BN
52 Week Low 425.70
52 Week High 631.75
VWAP = 448
With this we come to our trade:
Buy @/above 448
Target 1= 489.50
Target 2 = 538
Target 3 = 626.80
Suven Pharma high volume breakout1. Buy or Sell at your own risk
2. Don't risk more than 1%-2% of your capital as stop loss
3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price)
4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors)
5. Some other ways to sell stocks can be
a. 25% or 50% up in three weeks or less
b. Largest weekly price spread
c. Exhaustion gaps
d. Heavy daily volume without further upside
e. Largest one day price drop
after a consolidation since August 2021 NSE:SUVENPHAR gave a high volume break out today. It is a buy with a stop around Rs. 544.
Other fundamentals:
1. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women’s health. This segment makes up 78% of revenues. The company has a strong order book with new clients being consistently added. Most clients are the Big Pharma companies in Europe and the US. The company is looking to shift from Intermediate to API manufacturing and is in discussion with clients regarding this. The company has stated that it has the facilities for API manufacturing.
2. The Company is supplying intermediates – derived out of its CDMO competence – for two specialty chemical products (agrochemical) to large global conglomerates. In this segment, the company is currently working on two molecules with a new molecule to be developed next year.
3. The company has planned for a capex of Rs 600cr, a large part of which will be utilized in facility upgradation, technology enhancement and relocation spread over 3 years. This will be over and above the current ongoing capex of Rs 320cr spent over FY19-21. The capex would be mainly used for modernization of manufacturing facilities, relocation of R&D facilities and acquisition of new technologies. The company has already spent a Capex of Rs.94cr in 9MFY21 to expand its existing manufacturing facilities.
4. Suven Pharma is associated with more than 70 global companies. The company has an established market position in the CRAMS segment and is among the top five players in India who supply high-end intermediaries to innovators. Company is getting repeat business owing to long standing relationships with MNC companies. The industry has high entry barriers, needs deep technical expertise and is a sticky business.
5. Suven Pharma Inc. is a wholly owned subsidiary of SPL. It is a Special Purpose Vehicle created to invest in Rising Pharma Holdings Inc. Suven Pharma Inc. has 25 % holding in Rising Pharma Holdings Inc. Rising Pharma Holdings Inc. is a New Jersey, USA based pharmaceutical company focused on developing generic pharmaceuticals products in various therapeutic segments.
6. Company has reduced debt.
7. Debtor days have improved from 76.94 to 37.01 days.
8. Since June 2020 FII steak increased from 3.55 to 8.25.
9. Debt to equity at 0.10 (less than 1 is good), Interest Coverage at 104 (greater than 3 is good), Current ratio at 3.19 (greater than 1.5 is good).
SUVENPHAR | Good for Long NSE:SUVENPHAR
Cmp : 611
Breakout Retest
Try on pullback near 580
#Study, Learn & Earn.
If you love this post please like and comment your thoughts below. That will be a great motivation for me to post similar ideas ahead.
Disclaimer: All the information posting on this page are for the educational purpose only, we are not SEBI registered financial advisor. We wont recommend any BUY/SELL of stocks. Contact your financial advisor before taking any action.
Suven Pharma can show bullish upsideBlue trendline support became a resistance once stock dropped below the blueline support.
Stock is still taking support on the long time yellow trend line.
Breaking the downward yellow trendline and sustaining can become bullish, specially above 595.
Not a recommendation, just for my learning and sharing for getting comments
SUVENPHARMANote:
1. Views are personal and for educational purposes only. Recheck and take the trade as per your RR.
2. Always remember SL is your lifeline, not the big target...
3.Follow us for more patterns and like, share so that we feel it is helpful to many and share more patterns...
3. Views given here is not a tip rather it is for educational purpose... Aftermarket opens, the condition might change so learn to handle different conditions...
4. To learn more about patterns, Psychology behind the trade, and price action trading... contact us... Thanks...
Keep an eye ladies and gentlemen. Cheers and Happy Trading